Phase I Study of Idronoxil Combined With Radiation Treatment in Men With Metastatic Prostate Cancer
Phase of Trial: Phase I
Latest Information Update: 04 Sep 2017
At a glance
- Drugs Idronoxil (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 30 Aug 2017 Planned End Date changed from 31 Mar 2018 to 30 Sep 2018.
- 30 Aug 2017 Planned primary completion date changed from 31 Mar 2018 to 30 Sep 2018.
- 30 Aug 2017 Status changed from not yet recruiting to recruiting.